Biomica
Biomica is a clinical-stage biopharmaceutical company focused on developing microbiome-based therapeutics for cancer, immune-mediated, and infectious diseases. They leverage a proprietary computational platform called PRISM, which integrates AI, Big Data, and a comprehensive database for high-resolution microbiome profiling. This enables a faster, function-based drug discovery approach to identify and design minimal microbial consortia with maximized efficacy and minimized adverse effects. Founded by Evogene Ltd., Biomica aims to create best-in-class therapeutics for unmet medical needs.
Biomica
Biomica is a clinical-stage biopharmaceutical company focused on developing microbiome-based therapeutics for cancer, immune-mediated, and infectious diseases. They leverage a proprietary computational platform called PRISM, which integrates AI, Big Data, and a comprehensive database for high-resolution microbiome profiling. This enables a faster, function-based drug discovery approach to identify and design minimal microbial consortia with maximized efficacy and minimized adverse effects. Founded by Evogene Ltd., Biomica aims to create best-in-class therapeutics for unmet medical needs.